Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

Success with a smart VF is less about the screens and more about how people interact with the data and each other.

Leading clinicians, researchers & pharmaceutical innovators gathered to discuss the future of cancer treatment.

Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and ...

By 2050, nearly half of the world’s population is predicted to have myopia. Despite this growing trend, eye health remains a ...

Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. The pharmaceutical industry stands at a critical juncture.

As more pharma companies launch DTC platforms, marketers will need to develop strategies that take patient experience and transparency into account.

The integration of cannabinoids into mainstream pharmaceutical practices has been a topic of significant debate and interest over the past decade. As scientific research continues to unravel the ...

Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today. Rines kicks off by debunking ...

4 analysts have shared their evaluations of Collegium Pharmaceutical (NASDAQ:COLL) during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find ...

In the preceding three months, 27 analysts have released ratings for Biomarin Pharmaceutical (NASDAQ:BMRN), presenting a wide array of perspectives from bullish to bearish. In the table below, you'll ...

Ever wondered if BridgeBio Pharma is a hidden gem or already priced for perfection? You are not alone in asking if the stock’s current price points to opportunity or caution. BridgeBio Pharma’s stock ...